Antisense oligonucleotides targeting malarial aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum

scientific article published in July 1999

Antisense oligonucleotides targeting malarial aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0166-6851(99)00087-0
P698PubMed publication ID10477179

P2093author name stringNagel RL
Shear HL
Wanidworanun C
P2860cites workPlasmodium falciparum: identification and purification of the phosphoglycerate kinase of the malaria parasiteQ44274527
Aldolase activity of a Plasmodium falciparum protein with protective propertiesQ47910987
Expression and cellular localisation of hexokinase during the bloodstage development of Plasmodium falciparumQ48016227
A membrane network for nutrient import in red cells infected with the malaria parasiteQ48036713
Inhibition of Plasmodium falciparum proliferation in vitro by ribozymesQ48036924
Regular initiation of translation of Plasmodium berghei aldolase-2 after pre-mRNA splicingQ48085448
Ribozyme therapeuticsQ56883937
A colorimetric serum glucose determination using hexokinase and glucose-6-phosphate dehydrogenaseQ70640262
Inhibition of human interferon-gamma expression by antisense oligodeoxynucleotidesQ72756706
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform ExtractionQ25938986
Human malaria parasites in continuous cultureQ28131626
Plasmodium falciparum aldolase: gene structure and localizationQ28247447
Expression of Plasmodium falciparum lactate dehydrogenase in Escherichia coliQ28270273
Molecular analysis of Plasmodium falciparum hexokinaseQ30041881
Cloning of the triosephosphate isomerase gene of Plasmodium falciparum and expression in Escherichia coliQ30042866
Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotidesQ33634156
Drug-resistant malaria in children and in travelers.Q36704724
Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium falciparumQ37200628
Antisense oligonucleotide inhibition of gene expression: application to endocrine systems.Q38309662
Glycolytic pathway of the human malaria parasite Plasmodium falciparum: primary sequence analysis of the gene encoding 3-phosphoglycerate kinase and chromosomal mapping studiesQ38335737
Progress in antisense oligonucleotide therapeuticsQ38363412
Novel biochemical pathways in parasitic protozoaQ38715992
Molecular therapy for renal diseasesQ39182534
The treatment of malariaQ39590029
Chemically modified RNA: approaches and applicationsQ40484538
Review of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotides.Q40505939
Parasite-regulated membrane transport processes and metabolic control in malaria-infected erythrocytesQ40539958
Antisense oligonucleotides as therapeutic agents--is the bullet really magical?Q40834751
Malaria chemoprophylaxis for the travelerQ40913946
Antisense-oligonucleotide therapyQ40929324
Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrestQ41127037
Antisense oligonucleotides: towards clinical trialsQ41297750
Towards genomic drug therapy with antisense oligonucleotidesQ41337511
Identification and purification of glucose phosphate isomerase of Plasmodium falciparumQ44265948
P433issue1
P921main subjectPlasmodium falciparumQ311383
malariaQ12156
P304page(s)91-101
P577publication date1999-07-01
P1433published inMolecular and Biochemical ParasitologyQ15752756
P1476titleAntisense oligonucleotides targeting malarial aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum
P478volume102

Reverse relations

cites work (P2860)
Q43569857Aldolase genes of Plasmodium species
Q33679330Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis
Q92639063Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection
Q34058745Clinical proteomics of the neglected human malarial parasite Plasmodium vivax
Q41276143Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery
Q39347980Diagnosis of schistosomiasis using recombinant fructose-1,6-bisphosphate aldolase from a Formosan strain of Schistosoma japonicum
Q34086895Directional gene expression and antisense transcripts in sexual and asexual stages of Plasmodium falciparum
Q34792277Exploiting unique structural and functional properties of malarial glycolytic enzymes for antimalarial drug development
Q30046331Identification and recombinant expression of glyceraldehyde-3-phosphate dehydrogenase of Plasmodium falciparum
Q40599458Inhibition of Plasmodium falciparum proliferation in vitro by antisense oligodeoxynucleotides against malarial topoisomerase II.
Q37718844Potential biomarkers and their applications for rapid and reliable detection of malaria
Q34240829Reconstruction and flux-balance analysis of the Plasmodium falciparum metabolic network.
Q33550603The Alveolate Perkinsus marinus: biological insights from EST gene discovery
Q24813703Transcriptome analysis of antigenic variation in Plasmodium falciparum--var silencing is not dependent on antisense RNA
Q34671258Transcriptome sequencing and analysis of the zoonotic parasite Spirometra erinacei spargana (plerocercoids).
Q28539036Use of peptide nucleic acids to manipulate gene expression in the malaria parasite Plasmodium falciparum